vs
Side-by-side financial comparison of PROSPERITY BANCSHARES INC (PB) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $367.6M, roughly 1.7× PROSPERITY BANCSHARES INC). Royalty Pharma plc runs the higher net margin — 34.4% vs 31.6%, a 2.8% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 4.6%).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PB vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $367.6M | $622.0M |
| Net Profit | $116.3M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | — | 62.4% |
| Net Margin | 31.6% | 34.4% |
| Revenue YoY | — | 4.8% |
| Net Profit YoY | -10.7% | 2.9% |
| EPS (diluted) | $1.16 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $367.6M | — | ||
| Q4 25 | $275.0M | $622.0M | ||
| Q3 25 | $273.4M | $609.3M | ||
| Q2 25 | $267.7M | $578.7M | ||
| Q1 25 | $265.4M | $568.2M | ||
| Q4 24 | $267.8M | $593.6M | ||
| Q3 24 | $261.7M | $564.7M | ||
| Q2 24 | $258.8M | $537.3M |
| Q1 26 | $116.3M | — | ||
| Q4 25 | $139.9M | $214.2M | ||
| Q3 25 | $137.6M | $288.2M | ||
| Q2 25 | $135.2M | $30.2M | ||
| Q1 25 | $130.2M | $238.3M | ||
| Q4 24 | $130.1M | $208.2M | ||
| Q3 24 | $127.3M | $544.0M | ||
| Q2 24 | $111.6M | $102.0M |
| Q1 26 | — | — | ||
| Q4 25 | 65.1% | 62.4% | ||
| Q3 25 | 64.4% | 70.1% | ||
| Q2 25 | 64.3% | 36.3% | ||
| Q1 25 | 62.7% | 94.0% | ||
| Q4 24 | 62.0% | 60.9% | ||
| Q3 24 | 62.1% | — | ||
| Q2 24 | 55.2% | 50.2% |
| Q1 26 | 31.6% | — | ||
| Q4 25 | 50.9% | 34.4% | ||
| Q3 25 | 50.3% | 47.3% | ||
| Q2 25 | 50.5% | 5.2% | ||
| Q1 25 | 49.1% | 41.9% | ||
| Q4 24 | 48.6% | 35.1% | ||
| Q3 24 | 48.6% | 96.3% | ||
| Q2 24 | 43.1% | 19.0% |
| Q1 26 | $1.16 | — | ||
| Q4 25 | $1.48 | $0.49 | ||
| Q3 25 | $1.45 | $0.67 | ||
| Q2 25 | $1.42 | $0.07 | ||
| Q1 25 | $1.37 | $0.55 | ||
| Q4 24 | $1.36 | $0.46 | ||
| Q3 24 | $1.34 | $1.21 | ||
| Q2 24 | $1.17 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $8.2B | $9.7B |
| Total Assets | $43.6B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
| Q1 26 | $8.2B | — | ||
| Q4 25 | $7.6B | $9.7B | ||
| Q3 25 | $7.7B | $9.6B | ||
| Q2 25 | $7.6B | $9.5B | ||
| Q1 25 | $7.5B | $9.8B | ||
| Q4 24 | $7.4B | $10.3B | ||
| Q3 24 | $7.4B | $10.3B | ||
| Q2 24 | $7.3B | $9.8B |
| Q1 26 | $43.6B | — | ||
| Q4 25 | $38.5B | $19.6B | ||
| Q3 25 | $38.3B | $19.3B | ||
| Q2 25 | $38.4B | $18.3B | ||
| Q1 25 | $38.8B | $17.6B | ||
| Q4 24 | $39.6B | $18.2B | ||
| Q3 24 | $40.1B | $18.0B | ||
| Q2 24 | $39.8B | $17.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $78.3M | $827.1M | ||
| Q3 25 | $194.8M | $702.6M | ||
| Q2 25 | $98.2M | $364.0M | ||
| Q1 25 | $178.2M | $596.1M | ||
| Q4 24 | $-205.8M | $742.5M | ||
| Q3 24 | $274.6M | $703.6M | ||
| Q2 24 | $216.5M | $658.2M |
| Q1 26 | — | — | ||
| Q4 25 | $68.5M | — | ||
| Q3 25 | $185.7M | — | ||
| Q2 25 | $91.8M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $-210.7M | — | ||
| Q3 24 | $270.2M | — | ||
| Q2 24 | $211.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 24.9% | — | ||
| Q3 25 | 67.9% | — | ||
| Q2 25 | 34.3% | — | ||
| Q1 25 | 64.5% | — | ||
| Q4 24 | -78.7% | — | ||
| Q3 24 | 103.3% | — | ||
| Q2 24 | 81.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 3.86× | ||
| Q3 25 | 1.42× | 2.44× | ||
| Q2 25 | 0.73× | 12.06× | ||
| Q1 25 | 1.37× | 2.50× | ||
| Q4 24 | -1.58× | 3.57× | ||
| Q3 24 | 2.16× | 1.29× | ||
| Q2 24 | 1.94× | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
